Alpha 2.0
Login Register
» Articles » PMID: 32383370

Prevalence and Duration of Acute Loss of Smell or Taste in COVID-19 Patients

Overview
Journal J Korean Med Sci
Specialty General Medicine
Date 2020 May 9
PMID 32383370
Citations 270
Authors
Yonghyun Lee
Pokkee Min
Seonggu Lee
Shin Woo Kim
Affiliations
Soon will be listed here.
Abstract

Initially, acute loss of smell (anosmia) and taste (ageusia) was not considered important symptoms for coronavirus disease 2019 (COVID-19). To determine the prevalence of these symptoms and to evaluate their diagnostic significance, we (approximately 150 physicians of the Daegu Medical Association) prospectively collected data of cases of anosmia and ageusia from March 8, 2020, via telephone interview among 3,191 patients in Daegu, Korea. Acute anosmia or ageusia was observed in 15.3% (488/3,191) patients in the early stage of COVID-19 and in 15.7% (367/2,342) patients with asymptomatic-to-mild disease severity. Their prevalence was significantly more common among females and younger individuals ( = 0.01 and < 0.001, respectively). Most patients with anosmia or ageusia recovered within 3 weeks. The median time to recovery was 7 days for both symptoms. Anosmia and ageusia seem to be part of important symptoms and clues for the diagnosis of COVID-19, particularly in the early stage of the disease.

Citing Articles

Histopathology of the tongue in a hamster model of COVID-19.

Coggins J, Saito M, Cook R, Urata S, Urata M, Harsell N BMC Oral Health. 2025; 25(1):121.

PMID: 39849469 PMC: 11755867. DOI: 10.1186/s12903-025-05420-9.

Using Zebrafish to Study Multiciliated Cell Development and Disease States.

Nguyen T, Baker S, Rodriguez J, Arceri L, Wingert R Cells. 2024; 13(21.

PMID: 39513856 PMC: 11545745. DOI: 10.3390/cells13211749.

Polyunsaturated Fatty Acids as Potential Treatments for COVID-19-Induced Anosmia.

Wang Y, Lin C, Huang C Biomedicines. 2024; 12(9).

PMID: 39335598 PMC: 11428228. DOI: 10.3390/biomedicines12092085.

Determination of objective taste perception among Iranian medical sciences students during COVID‑19 pandemic in Yazd, Eastern Iran: a case-control pilot study.

Hajimaghsoodi S, Paydar E, Owlia F BMC Infect Dis. 2024; 24(1):997.

PMID: 39294570 PMC: 11409811. DOI: 10.1186/s12879-024-09897-7.

Characteristics and Impact of Long COVID at a Neurology Clinic.

Oh J, Chung E, Jung J, Lee J, Oh S Eur Neurol. 2024; 87(5-6):230-241.

PMID: 39208773 PMC: 11651337. DOI: 10.1159/000541172.

References
1.
Giacomelli A, Pezzati L, Conti F, Bernacchia D, Siano M, Oreni L . Self-reported Olfactory and Taste Disorders in Patients With Severe Acute Respiratory Coronavirus 2 Infection: A Cross-sectional Study. Clin Infect Dis. 2020; 71(15):889-890. PMC: 7184514. DOI: 10.1093/cid/ciaa330. View
2.
Kim E, Chin B, Kang C, Kim N, Kang Y, Choi J . Clinical Course and Outcomes of Patients with Severe Acute Respiratory Syndrome Coronavirus 2 Infection: a Preliminary Report of the First 28 Patients from the Korean Cohort Study on COVID-19. J Korean Med Sci. 2020; 35(13):e142. PMC: 7131901. DOI: 10.3346/jkms.2020.35.e142. View
3.
Guan W, Ni Z, Hu Y, Liang W, Ou C, He J . Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020; 382(18):1708-1720. PMC: 7092819. DOI: 10.1056/NEJMoa2002032. View
4.
Netland J, Meyerholz D, Moore S, Cassell M, Perlman S . Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2. J Virol. 2008; 82(15):7264-75. PMC: 2493326. DOI: 10.1128/JVI.00737-08. View
5.
Lechien J, Chiesa-Estomba C, De Siati D, Horoi M, Le Bon S, Rodriguez A . Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol. 2020; 277(8):2251-2261. PMC: 7134551. DOI: 10.1007/s00405-020-05965-1. View